Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement.
By W. Hochholzer, D. Trenk, H. Bestehorn, B. Fischer, C. Valina, Miroslaw Ferenc, M. Gick, A. Caputo, H. Büttner, F. Neumann. Journal of the American College of Cardiology, 2006
642 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Hematology, Oncology
View Paper: https://www.semanticscholar.org/paper/4f9b6a836697b5efc3e36a142e981ed25a367c87
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- N. Breet
- H. Bouman
- J. Kelder
- H. Ruven
- Sarah W Endemann
- Justin P Levisay
- Raghava R. Gollapudi
- V. Deneer
Citations in the corpus
- Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. (2008, result): “Notably, however, the low range of the 95% confidence interval was still above the mean PRU in the population, which is consistent with previous findings that patients with residual platelet reactivity above the median around the time of PCI are at higher risk for subsequent events.(9) Our threshold”
- Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. (2010, result): “The criterion standard light transmittance aggregometry has been the most widely used technique and has clearly demonstrated the relationship between high on-treatment platelet reactivity and subsequent atherothrombotic events.(4-6) Popular found an optimal diagnostic cut-off level discriminating pa”
- Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. (2011, neutral): “BMI, median (range) 31 (15-66) 31 (15-60) .”